These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16848762)

  • 1. beta-adrenergic receptor blockers and the treatment of vasovagal syncope: more nails in the coffin!
    Mathias CJ
    Clin Sci (Lond); 2006 Sep; 111(3):189-91. PubMed ID: 16848762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
    Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
    Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
    Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the effectiveness of beta-blocker therapy in vasovagal syncope.
    Kapoor JR
    J Am Coll Cardiol; 2008 Jun; 51(24):2372; author reply 2372-3. PubMed ID: 18549925
    [No Abstract]   [Full Text] [Related]  

  • 5. Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope.
    Baran I; Gemici K; Ozdemir B; Saraç M; Güllülü S; Aydinlar A; Cordan J
    Indian Heart J; 2003; 55(1):40-3. PubMed ID: 12760586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope.
    Eldadah BA; Pechnik SL; Holmes CS; Moak JP; Saleem AM; Goldstein DS
    Clin Sci (Lond); 2006 Sep; 111(3):209-16. PubMed ID: 16634720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
    Cohen TJ; Cayenne S; Black M; Doolittle S; Ibrahim B; Quan W
    J Invasive Cardiol; 1999 Jul; 11(7):457-60. PubMed ID: 10745573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent effect of β-blockers in preventing vasovagal syncope.
    Sheldon RS; Morillo CA; Klingenheben T; Krahn AD; Sheldon A; Rose MS
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):920-6. PubMed ID: 22972872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of tilting test negativization during beta-blocker treatment in patients with neurocardiogenic syncope.
    Vincenti A; Schena F; Cirò A; De Ceglia S
    Cardiologia; 1999 May; 44(5):461-8. PubMed ID: 10389353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers in syncope: the jury is still out.
    Sheldon RS; Raj SR; Rose S; Connolly SJ
    J Am Coll Cardiol; 2001 Dec; 38(7):2135-6. PubMed ID: 11738330
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness of pindolol for treatment of neurocardiogenic syncope.
    Nair N; Padder FA; Kutalek SP; Kantharia BK
    Am J Cardiol; 2004 Nov; 94(9):1189-91. PubMed ID: 15518620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced susceptibility to syncope during postural tilt in old age. Is beta-blockade protective?
    Lipsitz LA; Marks ER; Koestner J; Jonsson PV; Wei JY
    Arch Intern Med; 1989 Dec; 149(12):2709-12. PubMed ID: 2574566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasovagal syncope and beta-blockers].
    Anadolu Kardiyol Derg; 2001 Jun; 1(2):109. PubMed ID: 12109461
    [No Abstract]   [Full Text] [Related]  

  • 14. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials.
    Sheldon R; Connolly S;
    Card Electrophysiol Rev; 2003 Dec; 7(4):411-5. PubMed ID: 15071266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Overview on the management of vasovagal syncope].
    Filali T; Fehri W; Lahidheb D; Hajlaoui N; Salah O; Barakett N; Smiri Z; Mhenni H; Haouala H
    Tunis Med; 2007 Oct; 85(10):814-20. PubMed ID: 18236801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Components of clinical trials for vasovagal syncope.
    Sheldon R; Rose S
    Europace; 2001 Jul; 3(3):233-40. PubMed ID: 11467466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic changes during head-up tilt test and predictive value thereof in predicting the efficacy of metoprolol therapy in children with vasovagal syncope].
    Zhang QY; DU JB; Zhen JL; Li WZ; Wang YL
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1260-2. PubMed ID: 17686261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasovagal syncope--standards of management, clinical and diagnostic problems].
    Matyszczak-Toniak L; Kargul W
    Wiad Lek; 2007; 60(3-4):162-6. PubMed ID: 17726870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers no better than placebo in the treatment of vasovagal syncope.
    Phillips J; Krist A
    J Fam Pract; 2002 Nov; 51(11):921. PubMed ID: 12485542
    [No Abstract]   [Full Text] [Related]  

  • 20. Tilt training: does it have a role in preventing vasovagal syncope?
    Gurevitz O; Barsheshet A; Bar-Lev D; Zimlichman E; Rosenfeld GF; Benderly M; Luria D; Amital H; Kreiss Y; Eldar M; Glikson M
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1499-505. PubMed ID: 18070305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.